Drugs by Therapeutic Area Market Research

Total Records (3)
Show

Ischemia Reperfusion Injury Therapeutics Market By Product (BAY-606583, GS-459679, APP-103, KN-93, Others), By Injury Type (Heart Injury, Kidney Injury, Intestine Injury, Others), By Therapeutic Hypothermia (Cyclosporin, Stem Cell Therapy, Hydrogen Sulphide Treatment, Others), By Treatment Form (Drug Therapy, Medicated Gases, Others), By End-user (Hospitals, Specialty Clinics, Others) - Growth, Share, Opportunities & Competitive Analysis, 2023 – 2031

The market for ischemia-reperfusion injury therapeutics is anticipated to expand at a CAGR of 6.2% during the forecast period of 2023 to 2031. Reperfusion injury, also known as Ischemia-Reperfusion Injury, is the tissue damage that occurs when blood supply returns to ischemic tissue. Increased tissue damage and fluid filtration across the tissue are the primary factors driving the market's expansion.

4500
24 Mar, 2023

Nutraceutical Ingredients Market By Ingredients, By Application, By Therapeutic Area - Growth, Future Prospects And Competitive Analysis, 2022 - 2030

Nutraceutical is a combined term for nutrition and pharmaceutical products that claim to exhibit immense health benefits. Considerable interest for nutraceuticals grew due to the bioactive components of nutraceuticals that have additive nutritional value to human health. Increasing economies of developing nations along with countries with emerging economies is expected to expand the nutraceuticals industry.

4500
14 Nov, 2017

Autoinjectors Market By Device (Manual Injection Autoinjectors, Automated Injection Autoinjectors, Reusable Autoinjectors, Disposable Autoinjectors, Variable Dose Autoinjectors & Smart Autoinjectors), By Therapeutic Area (Anaphylaxis, Hormones, Anticoagulants, Emergency Medicine, Autoimmune Diseases, Infectious Diseases, Hematopoietics, Neurology, Reproductive Health) - Growth, Future Prospects and Competitive Assessment, 2021 - 2029

With ring trend towards self-administration of drugs, injectable drug delivery solutions such as autoinjectors and pen injectors demonstrate a noteworthy growth potential in the near future. Driven by industry demands, the biopharmaceutical companies worldwide have since introduced a big range of drug injection solutions. In fact, it is also estimated that a significant section of new product entries to the FDA will be drug-device combinations.

4325
25 Jul, 2016
Filter

Key Sectors

Drugs by Therapeutic Area